Boundless Bio, Inc. (BOLD) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

In this article, we are going to take a look at where Gossamer Bio, Inc. (NASDAQ:GOSS) stands against other hot biotech stocks under $5. The biotechnology sector is gaining new momentum with ...

Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved ...

bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for curative severe genetic diseases in the United States. The company’s product candidates ...

Excluding items, Instil Bio, Inc. reported adjusted earnings of -$15.51 million or -$2.39 per share for the period. Instil Bio, Inc. earnings at a glance (GAAP) : -Earnings (Q1): -$24.30 Mln.

PALO ALTO, Calif.--(BUSINESS WIRE)--Peak Bio, Inc. ("Peak Bio" or the "Company") (NASDAQ: PKBO), a clinical-stage biopharmaceutical company focused on developing the ...

Climb Bio, Inc. has announced an exclusive licensing agreement with Beijing Mabworks Biotech Co., Ltd. to develop and commercialize CLYM116, an anti-APRIL monoclonal antibody aimed at treating IgA ...

In this article, we are going to take a look at where Gossamer Bio, Inc. (NASDAQ:GOSS) stands against other stocks under $10 that will triple. As we delve into the discussion on stocks that will ...

PHILADELPHIA--(BUSINESS WIRE)--Tolerance Bio, Inc., a biopharmaceutical company pioneering a novel approach to increasing healthspan by preserving, restoring, and manipulating the function of the ...

Climb Bio, Inc. operates as a clinical-stage biotechnology company. It develops therapeutics for patients with immune-mediated diseases. Its lead product candidate, budoprutug, is an anti-CD19 ...